Senior Manager, Evidence and Access Strategy

📋 Description

• Reporting to the Director of Evidence Strategy and Access for Europe, within the Medical Affairs team.

• Work collaboratively with Sales, Clinical Affairs, and the Global Access Value and Economics teams to establish robust frameworks for evaluating robotics-assisted technologies.

• Oversee market access, reimbursement, and funding initiatives for established therapies and rapidly advancing technologies throughout Germany, Switzerland, and Austria (DACH).

• Define and strategically shape the most suitable access pathways—including coverage mechanisms (e.g. DRGs, procedure codes, add-on payments), high-quality HTA submissions, and funding negotiations—to facilitate the timely adoption of MedTech and capital equipment in both hospital and outpatient environments.

• Build and maintain a strong network of pertinent opinion leaders across providers, payers, and policymakers.

• Manage relationships with key national and local stakeholders, collaborating closely with Key Opinion Leaders and scientific societies to enhance engagement, advocacy, and alignment in discussions with national payer and reimbursement decision-makers.

• Lead the initiation and management of consultancy engagements across a diverse portfolio of market access initiatives.

• Ensure optimal reimbursement by guaranteeing that our solutions are appropriately coded, covered, and funded throughout the region.

• Analyze funding pathways, assess policy and payment system changes, and translate these insights into actionable strategies that promote clinical adoption and commercial success.

• Develop and implement strategies for market access at both national and local levels, leading, coordinating, or supporting HTA activities, including the preparation and submission of national or regional HTA dossiers, engagement with assessment bodies, and alignment of clinical and economic evidence.

• Serve as the primary HTA expert for the robotics-assisted bronchoscopy business unit.

• Strategically utilize clinical data and real-world evidence (RWD) to inform and shape market access strategies, reinforcing value narratives to support coverage, reimbursement, and funding goals across the region.

⛳️ Requirements

• Health Economics training and experience in the medical device sector are essential.

• Comprehensive understanding of the DACH healthcare markets, including governmental and policy requirements for medical devices, along with an established network of key stakeholders (payers, policymakers, hospital decision-makers, and KOLs) to effectively influence market access and funding strategies.

• Relevant experience in Market Access / Reimbursement strategy, value demonstration, value dossier, and value communication is also important.

• Proficiency in both German and English is essential, as this position is part of an international Market Access business unit.

• A degree in Health Economics, Public Health, Life Sciences, or a related field (PharmD preferred) is required, with a postgraduate qualification being a plus.

• A minimum of 5+ years of relevant experience in market access, health economics, or reimbursement, preferably in the MedTech sector, although pharmaceutical backgrounds will be considered.

• Strong knowledge of the German healthcare and reimbursement system (experience with Austria and Switzerland is an advantage).

• Senior-level engagement with key German market access stakeholders (e.g. payers, HTA bodies, policymakers, and provider decision-makers).

• Excellent strategic thinking and analytical skills.

• Fluent communication abilities in both German and English, capable of confidently presenting and writing clearly for professional audiences.

• Willingness to travel frequently (approximately 50-60%) across the DACH region to engage with payers, hospital stakeholders, policymakers, and KOLs.

• Experience in field reimbursement in a hospital setting.

🏝️ Benefits

• Health Economics training and experience within the medical device sector is vital.

• Detailed understanding of the DACH healthcare markets, including government and policy requirements for medical devices, combined with an established network of key stakeholders (payers, policymakers, hospital decision-makers, and KOLs) to effectively inform and influence market access and funding strategies.

• Previous Market Access / Reimbursement strategy experience, value demonstration, value dossier, and value communication experience is also important.

• Fluency in German and English is essential as this role will be part of an international Market Access business unit.

• Degree in Health Economics, Public Health, Life Sciences, or related field (PharmD preferred) (a postgraduate qualification is a plus).

• At least 5+ years of relevant experience in market access, health economics, or reimbursement, ideally in the MedTech sector, though pharma backgrounds will be considered.

• Strong understanding of the German healthcare and reimbursement system (experience with Austria and Switzerland is a plus).

• Senior-level stakeholder engagement with key German market access stakeholders (e.g. payers, HTA bodies, policymakers, and provider decision-makers).

• Strong strategic thinking and analytical capabilities.

• Fluent communication skills in both German and English, with the ability to present confidently and write clearly for professional audiences.

• Requires frequent travel (approximately 50-60%) across the DACH region to engage with payers, hospital stakeholders, policymakers, and KOL.

• Field reimbursement experience in a Hospital setting.